Home  /  Webcasts  /  PHAC: COVID-19 Vaccines Emerging Issues: Allergies and LDV Syringe Discussion

PHAC: COVID-19 Vaccines Emerging Issues: Allergies and LDV Syringe Discussion

Introduction

This moderated webinar is for health care providers who are administering COVID-19 vaccines. It describes allergy-related contraindications or precautions to COVID-19 vaccination and the features and management of anaphylaxis following administration of COVID-19 vaccines.

Related Items:

The National Collaborating Centre for Infectious Diseases presents:

The Public Health Agency of Canada (PHAC) Webinar for Health Care Providers:

Emerging Issues on COVID-19 Vaccines:

  • Allergies and Anaphylaxis following administration of COVID-19 vaccines, presentation with live Q&A
  • Low Dead Volume Syringes, live Q&A panel

This moderated webinar is for health care providers who are administering COVID-19 vaccines.

Resources

Allergies and Anaphylaxis following administration of COVID-19 vaccines slidesDownload
Low dead volume syringes slidesDownload

Date And Time

Wednesday, February 10, 2021

1:00 PM – 3:00 PM EST (12:00 PM – 2:00 PM CST)

Presentation: Allergies and Anaphylaxis following administration of COVID-19 vaccines: This presentation describes allergy-related contraindications or precautions to COVID-19 vaccination, and the features and management of anaphylaxis following administration of COVID-19 vaccines.

Speakers: Dr. Bryna Warshawsky and Dr. Catherine Dickson, Public Health Agency of Canada; and guest experts

Panel Q&A: Low Dead Volume Syringes

Experts discuss and answer questions on low dead volume syringes.

Presenters: Dr. Bryna Warshawsky, Sean Meredith, and guest experts

Moderator: Dr. April Killikelly, Public Health Agency of Canada

Speakers

Bryna Warshawsky is a Medical Advisor at the Public Health Agency of Canada working on the COVID-19 vaccine roll-out response. She is also an Adjunct Assistant Professor in the Department of Epidemiology and Biostatistics at Western University and a past Chair of the National Advisory Committee on Immunization. She has worked as the Associate Medical Officer of Health for the Middlesex-London Health Unit and as a Public Health Physician at Public Health Ontario.

Catherine Dickson is a public health and preventive medicine physician working as a medical advisor for the Centre for Immunization and Respiratory Infectious Disease at the Public Health Agency of Canada, where she works on several aspects of vaccine preventable disease epidemiology, including vaccine safety. Catherine previously worked as a Field Epidemiologist in the Public Health Agency of Canada’s Canadian Field Epidemiology Program.